1. Home
  2. OGN vs FORM Comparison

OGN vs FORM Comparison

Compare OGN & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • FORM
  • Stock Information
  • Founded
  • OGN 1923
  • FORM 1993
  • Country
  • OGN United States
  • FORM United States
  • Employees
  • OGN N/A
  • FORM N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • FORM Semiconductors
  • Sector
  • OGN Health Care
  • FORM Technology
  • Exchange
  • OGN Nasdaq
  • FORM Nasdaq
  • Market Cap
  • OGN 2.5B
  • FORM 2.7B
  • IPO Year
  • OGN N/A
  • FORM N/A
  • Fundamental
  • Price
  • OGN $9.33
  • FORM $29.19
  • Analyst Decision
  • OGN Hold
  • FORM Buy
  • Analyst Count
  • OGN 4
  • FORM 8
  • Target Price
  • OGN $18.00
  • FORM $38.14
  • AVG Volume (30 Days)
  • OGN 4.7M
  • FORM 799.0K
  • Earning Date
  • OGN 08-05-2025
  • FORM 10-29-2025
  • Dividend Yield
  • OGN 0.85%
  • FORM N/A
  • EPS Growth
  • OGN N/A
  • FORM N/A
  • EPS
  • OGN 2.69
  • FORM 0.57
  • Revenue
  • OGN $6,281,000,000.00
  • FORM $764,554,000.00
  • Revenue This Year
  • OGN N/A
  • FORM $2.58
  • Revenue Next Year
  • OGN $1.36
  • FORM $7.33
  • P/E Ratio
  • OGN $3.50
  • FORM $51.97
  • Revenue Growth
  • OGN N/A
  • FORM 8.30
  • 52 Week Low
  • OGN $8.01
  • FORM $22.58
  • 52 Week High
  • OGN $22.67
  • FORM $50.79
  • Technical
  • Relative Strength Index (RSI)
  • OGN 43.86
  • FORM 43.93
  • Support Level
  • OGN $8.95
  • FORM $29.06
  • Resistance Level
  • OGN $9.25
  • FORM $29.91
  • Average True Range (ATR)
  • OGN 0.28
  • FORM 0.93
  • MACD
  • OGN 0.00
  • FORM 0.25
  • Stochastic Oscillator
  • OGN 22.54
  • FORM 60.50

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: